|
|
|||
| |||||||||||||||||||||||||||||||||||||||
We previously showed that patients with primary biliary cirrhosis and extreme hypercholesterolemia (total cholesterol level, >25.86 mmol per liter) had a substantial proportion of circulating lipoprotein X.3 Further in vitro studies revealed that lipoprotein X reduces the atherogenicity of
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |